People · Operator

Tracy Gilbert Saxton

Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals

1
Companies
1
Filings
$53.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Lumos Pharma, Inc.PharmaceuticalsSeries B$53.5M$1.2B2016
Operator network

Tracy Gilbert Saxton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jon S. Saxe · 5 companies · 1 sharedJon S. SaxeKevin M. Lalande · 2 companies · 1 sharedKevin M. LalandeRichard John Hawkins · 2 companies · 1 sharedRichard John Hawk…Cameron Gilbert Wheeler · 1 companies · 1 sharedCameron Gilbert W…Edward Gilbert Mathers · 1 companies · 1 sharedEdward Gilbert Ma…Edward J. Mathers · 1 companies · 1 sharedEdward J. MathersGeorge Gilbert Cloyd · 1 companies · 1 sharedGeorge Gilbert Cl…G. Gilbert Cloyd · 1 companies · 1 sharedG. Gilbert CloydKevin S. Lelande · 1 companies · 1 sharedKevin S. LelandeMichele Gilbert Park · 1 companies · 1 sharedMichele Gilbert P…Robert J. Heft · 1 companies · 1 sharedRobert J. HeftRobert S. Heft · 1 companies · 1 sharedRobert S. HeftLumos Pharma, Inc. · $53.5M raisedLumos Pharma, Inc.Tracy Gilbert SaxtonTS
Tracy Gilbert Saxton Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Tracy Gilbert Saxton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jon S. Saxe15
Richard John Hawkins12
Kevin M. Lalande12
Kevin S. Lelande11
Robert S. Heft11
Cameron Gilbert Wheeler11
Michele Gilbert Park11
Edward Gilbert Mathers11
Edward J. Mathers11
George Gilbert Cloyd11
Robert J. Heft11
G. Gilbert Cloyd11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.